Virax Biolabs Preparing T-Cell Testing Platform to Provide Consumers With Immune Status Info

by Kelsy Ketchum

COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

Assessing Adaptive Immune Responses to Viruses to Inform Decisions about Vaccinations with Dr. Tomasz George

By Karen Jagoda

In Every Crisis There Is An Opportunity – Interview with Chief Executive, James Foster

by Tom Hickey

Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

Virax Biolabs Announces Closing of $3.8 Million Private Placement

Virax Biolabs Announces $3.8 Million Private Placement

Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit

Virax Biolabs Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study

Monkeypox Diagnosis and Immune Profiling Using Proprietary T cell Test Technology